Page last updated: 2024-08-17

cordycepin and Parkinsonian Disorders

cordycepin has been researched along with Parkinsonian Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ge, XQ; He, Y; Hong, YX; Huang, WM; Qiu, L; Sun, Y; Tang, PC; Yu, BC; Zhang, X; Zhang, XL; Zhang, XY1
Cheng, C; Zhu, X1

Other Studies

2 other study(ies) available for cordycepin and Parkinsonian Disorders

ArticleYear
Anti-inflammatory and neuroprotective effects of natural cordycepin in rotenone-induced PD models through inhibiting Drp1-mediated mitochondrial fission.
    Neurotoxicology, 2021, Volume: 84

    Topics: Animals; Anti-Inflammatory Agents; Deoxyadenosines; Dose-Response Relationship, Drug; Dynamins; Insecticides; Male; Mitochondrial Dynamics; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein; Parkinsonian Disorders; PC12 Cells; Rats; Rats, Sprague-Dawley; Rotenone

2021
Cordycepin mitigates MPTP-induced Parkinson's disease through inhibiting TLR/NF-κB signaling pathway.
    Life sciences, 2019, Apr-15, Volume: 223

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Line, Tumor; Deoxyadenosines; Lipopolysaccharides; Male; Microglia; Motor Activity; Neuroprotective Agents; NF-kappa B; Oxidative Stress; Parkinsonian Disorders; Rats, Sprague-Dawley; Signal Transduction; Toll-Like Receptors

2019